Complement in health and disease

被引:167
|
作者
Carroll, Maria V. [1 ]
Sim, Robert B. [1 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
关键词
Complement; Innate immunity; Blood plasma; Collectins; Inflammation; Phagocytosis; Opsonisation; Autoimmunity; Infection; Disease; MANNOSE-BINDING PROTEIN; PATTERN-RECOGNITION MOLECULES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN FACTOR-H; LECTIN PATHWAY ACTIVATION; GUINEA-PIG SERUM; L-FICOLIN; 1ST COMPONENT; ALTERNATIVE-PATHWAY; SERINE PROTEASES;
D O I
10.1016/j.addr.2011.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complement system consists of about 35-40 proteins and glycoproteins present in blood plasma or on cell surfaces. Its main biological function is to recognise "foreign" particles and macromolecules, and to promote their elimination either by opsonisation or lysis. Although historically complement has been studied as a system for immune defence against bacteria, it has an important homeostatic role in which it recognises damaged or altered "self" components. Thus complement has major roles in both immune defence against microorganisms, and in clearance of damaged or "used" host components. Since complement proteins opsonise or lyse cells, complement can damage healthy host cells and tissues. The system is regulated by many endogenous regulatory proteins. Regulation is sometimes imperfect and both too much and too little complement activation is associated with many diseases. Excessive or inappropriate activation can cause tissue damage in diseases such as rheumatoid arthritis, age-related macular degeneration (AMD), multiple sclerosis, ischemia-reperfusion injury (e.g. ischemic stroke). Insufficient complement activity is associated with susceptibility to infection (mainly bacterial) and development of autoimmune disease, like SLE (systemic lupus erythematosus). (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:965 / 975
页数:11
相关论文
共 50 条
  • [41] Complement in lung disease
    Sarma, Vidya J.
    Huber-Lang, Markus
    Ward, Peter A.
    AUTOIMMUNITY, 2006, 39 (05) : 387 - 394
  • [42] Complement and disease - Introduction
    Hugli, TE
    IMMUNOPHARMACOLOGY, 1997, 38 (1-2): : 1 - 1
  • [43] Complement in Glomerular Disease
    Vernon, Katherine A.
    Cook, H. Terence
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2012, 19 (02) : 84 - 92
  • [44] COMPLEMENT PROTEINS AND COMPLEMENT INHIBITORS IN ALZHEIMERS-DISEASE
    MCGEER, PL
    MCGEER, EG
    RESEARCH IN IMMUNOLOGY, 1992, 143 (06): : 621 - 623
  • [45] Glomerular basement membrane heparan sulfate in health and disease A regulator of local complement activation
    Borza, Dorin-Bogdan
    MATRIX BIOLOGY, 2017, 57-58 : 299 - 310
  • [46] STUDIES ON 3RD COMPONENT OF COMPLEMENT (C3) IN HEALTH AND DISEASE
    SRIVASTAVA, N
    SRIVASTAVA, LM
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1977, 14 (01): : 8 - 8
  • [47] HYDATID DISEASE AND COMPLEMENT SYSTEM
    KASSIS, AI
    TANNER, CE
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1975, 66 (01): : 52 - 52
  • [48] SERUM COMPLEMENT IN HEPATOBILIARY DISEASE
    MANDEL, EE
    LANGE, K
    AMERICAN JOURNAL OF MEDICINE, 1955, 19 (04): : 646 - 647
  • [49] COMPLEMENT IN NORMAL AND DISEASE PROCESSES
    COOPER, NR
    FOGEL, BJ
    JOURNAL OF PEDIATRICS, 1967, 70 (06): : 982 - +
  • [50] Meningococcal disease and the complement system
    Lewis, Lisa A.
    Ram, Sanjay
    VIRULENCE, 2014, 5 (01) : 98 - 126